Reactive arthritis (ReA) is one of the most common arthritides affecti
ng young adults. in most cases it follows urogenital or enteric bacter
ial infection, but its pathogenesis is not fully understood. It is gen
erally considered a sterile arthritis which appears to involve immune
response to bacterial organisms and genetic host susceptibility associ
ated with the presence of HLA-B27 antigen. New findings suggest that i
n some ReA cases, viable bacteria are present inside the joints, and t
hese organisms may cause the disease and trigger the inflammatory resp
onse. ReA manifests clinically as a rheumatoid factor negative oligoar
thritis associated with enthesopathy and certain mucosal and skin lesi
ons. Laboratory findings in ReA are non-specific. Although concepts of
its pathogenesis are still evolving, so-called ReA remains an importa
nt condition to be distinguished from rheumatoid arthritis. Prognosis
is generally better. Treatments with known effects in some cases inclu
de non-steroidal antiinflammatory drugs, intra-articular corticosteroi
ds, oral tetracyclines and sulphasalazine. The occasional chronic and
severe ReA may be very difficult to treat.